after stratification for sex and performance status , patients were randomly assigned to receive chemotherapy with methotrexate , doxorubicin ( adriamycin ; adria laboratories , columbus , oh ) , cyclophosphamide , and lomustine ( ccnu ) ( macc ) , or macc plus warfarin ( macc + w ) , or mitomycin , etoposide , cisplatin , and hexamethylmelamine alternating with macc ( meph/macc ) .
C0010583
cyclophosphamide
C0065473
macc